291 related articles for article (PubMed ID: 29059163)
1. Molecular genetics and cellular events of K-Ras-driven tumorigenesis.
Jinesh GG; Sambandam V; Vijayaraghavan S; Balaji K; Mukherjee S
Oncogene; 2018 Feb; 37(7):839-846. PubMed ID: 29059163
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence.
Graziano S; Johnston R; Deng O; Zhang J; Gonzalo S
Oncogene; 2016 Oct; 35(41):5362-5376. PubMed ID: 27041576
[TBL] [Abstract][Full Text] [Related]
3. The Blebbishield Emergency Program Overrides Chromosomal Instability and Phagocytosis Checkpoints in Cancer Stem Cells.
Jinesh GG; Kamat AM
Cancer Res; 2017 Nov; 77(22):6144-6156. PubMed ID: 28855211
[TBL] [Abstract][Full Text] [Related]
4. Mouse models of K-ras-initiated carcinogenesis.
Janssen KP; Abal M; El Marjou F; Louvard D; Robine S
Biochim Biophys Acta; 2005 Nov; 1756(2):145-54. PubMed ID: 16126346
[TBL] [Abstract][Full Text] [Related]
5. Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics.
Singh SK; Ellenrieder V
Gut; 2013 Sep; 62(9):1364-72. PubMed ID: 23408353
[TBL] [Abstract][Full Text] [Related]
6. Role of proto-oncogene activation in carcinogenesis.
Anderson MW; Reynolds SH; You M; Maronpot RM
Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
[TBL] [Abstract][Full Text] [Related]
7. How do K-RAS-activated cells evade cellular defense mechanisms?
Lee YS; Bae SC
Oncogene; 2016 Feb; 35(7):827-32. PubMed ID: 25961920
[TBL] [Abstract][Full Text] [Related]
8. Genomic instability and histone H3 phosphorylation induction by the Ras-mitogen activated protein kinase pathway in pancreatic cancer cells.
Espino PS; Pritchard S; Heng HH; Davie JR
Int J Cancer; 2009 Feb; 124(3):562-7. PubMed ID: 19004007
[TBL] [Abstract][Full Text] [Related]
9. Kirsten Ras* oncogene: significance of its discovery in human cancer research.
Tsuchida N; Murugan AK; Grieco M
Oncotarget; 2016 Jul; 7(29):46717-46733. PubMed ID: 27102293
[TBL] [Abstract][Full Text] [Related]
10. Interplay among Drosophila transcription factors Ets21c, Fos and Ftz-F1 drives JNK-mediated tumor malignancy.
Külshammer E; Mundorf J; Kilinc M; Frommolt P; Wagle P; Uhlirova M
Dis Model Mech; 2015 Oct; 8(10):1279-93. PubMed ID: 26398940
[TBL] [Abstract][Full Text] [Related]
11. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B
Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma protein (pRB) was significantly phosphorylated through a Ras-to-MAPK pathway in mutant K-ras stably transfected human adrenocortical cells.
Chen YF; Chiu HH; Wu CH; Wang JY; Chen FM; Tzou WH; Shin SJ; Lin SR
DNA Cell Biol; 2003 Oct; 22(10):657-64. PubMed ID: 14611687
[TBL] [Abstract][Full Text] [Related]
13. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
14. DA-Raf, a dominant-negative antagonist of the Ras-ERK pathway, is a putative tumor suppressor.
Kanno E; Kawasaki O; Takahashi K; Takano K; Endo T
Exp Cell Res; 2018 Jan; 362(1):111-120. PubMed ID: 29129563
[TBL] [Abstract][Full Text] [Related]
15. Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer.
Wang P; Zhu CF; Ma MZ; Chen G; Song M; Zeng ZL; Lu WH; Yang J; Wen S; Chiao PJ; Hu Y; Huang P
Oncotarget; 2015 Aug; 6(25):21148-58. PubMed ID: 26020803
[TBL] [Abstract][Full Text] [Related]
16. [Mouse models of K-ras-initiated oncogenesis].
Barrière C; Marjou FE; Louvard D; Robine S
Bull Cancer; 2009 Dec; 96 Suppl():S5-14. PubMed ID: 20034865
[TBL] [Abstract][Full Text] [Related]
17. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair.
Sallmyr A; Fan J; Rassool FV
Cancer Lett; 2008 Oct; 270(1):1-9. PubMed ID: 18467025
[TBL] [Abstract][Full Text] [Related]
18. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
19. The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis.
Xu G; Yang Z; Ding Y; Liu Y; Zhang L; Wang B; Tang M; Jing T; Jiao K; Xu X; Chen Z; Xiang L; Xu C; Fu Y; Zhao X; Jin W; Liu Y
Oncogene; 2021 Sep; 40(36):5482-5494. PubMed ID: 34294846
[TBL] [Abstract][Full Text] [Related]
20. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
